DE69637941D1 - Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung - Google Patents

Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung

Info

Publication number
DE69637941D1
DE69637941D1 DE69637941T DE69637941T DE69637941D1 DE 69637941 D1 DE69637941 D1 DE 69637941D1 DE 69637941 T DE69637941 T DE 69637941T DE 69637941 T DE69637941 T DE 69637941T DE 69637941 D1 DE69637941 D1 DE 69637941D1
Authority
DE
Germany
Prior art keywords
hemoglobin
compounds
modified
proteins
hemoglobinary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69637941T
Other languages
English (en)
Inventor
Stephen P Trimble
David C Anderson
Antony J Mathews
Spencer Anthony-Cahill
David A Marquardt
Dominic G Madril
Bruce A Kerwin
Janet K Epp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Biotech Technology SARL
Original Assignee
Baxter Biotech Technology SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Biotech Technology SARL filed Critical Baxter Biotech Technology SARL
Application granted granted Critical
Publication of DE69637941D1 publication Critical patent/DE69637941D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
DE69637941T 1995-06-07 1996-06-06 Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung Expired - Lifetime DE69637941D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/487,431 US5844090A (en) 1994-05-09 1995-06-07 Modified hemoglobin-like compounds
PCT/US1996/010420 WO1996040920A1 (en) 1992-11-06 1996-06-06 Modified hemoglobin-like compounds and methods of purifying same

Publications (1)

Publication Number Publication Date
DE69637941D1 true DE69637941D1 (de) 2009-07-09

Family

ID=23935700

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637941T Expired - Lifetime DE69637941D1 (de) 1995-06-07 1996-06-06 Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung

Country Status (8)

Country Link
US (1) US5844090A (de)
EP (1) EP0832228B1 (de)
JP (2) JPH11507388A (de)
AT (1) ATE432349T1 (de)
AU (1) AU714185B2 (de)
CA (1) CA2219242A1 (de)
DE (1) DE69637941D1 (de)
WO (1) WO1996040920A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150506A (en) * 1989-05-10 2000-11-21 Baxter Biotech Technology Sarl Modified hemoglobin-like compounds and methods of purifying same
WO1997023631A2 (en) * 1995-12-22 1997-07-03 Somatogen, Inc. Globins containing binding domains
AU6340998A (en) * 1997-02-28 1998-09-18 Somatogen, Inc. Permuted hemoglobin-like proteins
CA2299049C (en) * 1997-05-02 2008-07-15 Baxter Biotech Technology S.A.R.L. Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
EP1950298A3 (de) 1997-05-02 2008-12-24 Baxter Biotech Technology S.A.R.L. Hämoglobinmutanten mit erhöhtem Löslichkeitswert und/oder reduzierter Stickoxidspülung
WO2000003737A2 (en) * 1998-07-17 2000-01-27 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Water-soluble drugs and methods for their production
US6894150B1 (en) * 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
JP5099951B2 (ja) 1999-11-12 2012-12-19 バクスター・インターナショナル・インコーポレイテッド 副作用が減少されたヘモグロビン組成物
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
US7494974B2 (en) * 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US4001401A (en) * 1975-02-02 1977-01-04 Alza Corporation Blood substitute and blood plasma expander comprising polyhemoglobin
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
DE3144705C2 (de) * 1981-11-11 1983-12-08 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines lagerstabilen, vernetzten Hämoglobinpräparates mit hoher Sauerstoff-Transportkapazität, sowie das nach diesem Verfahren hergestellte Hämoglobinpräparat
US4529719A (en) * 1983-05-04 1985-07-16 Tye Ross W Modified crosslinked stroma-free tetrameric hemoglobin
US4598064A (en) * 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
US4600531A (en) * 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4584130A (en) * 1985-03-29 1986-04-22 University Of Maryland Intramolecularly cross-linked hemoglobin and method of preparation
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
ATE246246T1 (de) * 1989-05-10 2003-08-15 Baxter Biotech Tech Sarl Herstellung von hämoglobin und analogen davon in nicht-erythrozytzellen
US5599907A (en) * 1989-05-10 1997-02-04 Somatogen, Inc. Production and use of multimeric hemoglobins
US5545727A (en) * 1989-05-10 1996-08-13 Somatogen, Inc. DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
DE69133089T2 (de) * 1990-04-16 2003-04-17 Apex Bioscience Inc Expression von rekombinantem hämoglobin in hefe
AU668856B2 (en) * 1990-12-20 1996-05-23 University Of Alabama Research Foundation, The Transgenic, cross-linked hemoglobin
US5665869A (en) * 1993-11-15 1997-09-09 Somatogen, Inc. Method for the rapid removal of protoporphyrin from protoporphyrin IX-containing solutions of hemoglobin

Also Published As

Publication number Publication date
WO1996040920A1 (en) 1996-12-19
EP0832228A1 (de) 1998-04-01
JPH11507388A (ja) 1999-06-29
EP0832228B1 (de) 2009-05-27
CA2219242A1 (en) 1996-12-19
JP2006206592A (ja) 2006-08-10
ATE432349T1 (de) 2009-06-15
AU714185B2 (en) 1999-12-23
US5844090A (en) 1998-12-01
JP3991057B2 (ja) 2007-10-17
AU6179096A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
LU91759I2 (fr) Denosumab et ses dérivés pharmaceutique acceptables (PROLIA®)
DE69002248D1 (de) 1,2-cyclohexylaminoarylamide zu verwendung als analgetika.
DK1240337T3 (da) Fremgangsmåder og præparater til forlængelse af elimeneringshalveringstider af bioaktive forbindelser
DE3484691D1 (de) Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0815114T3 (da) Nucleinsyresyntese ved anvendelse af lysfraspaltelige beskyttende grupper
FI952328A0 (fi) eck-respetorin lignandeja
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
DE3854004T2 (de) Verfahren zur Herstellung von N-substituiertem Amin.
DE69637941D1 (de) Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung
ATE135368T1 (de) Aminosäurederivate mit reninhemmenden eigenschaften, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
DE69734096D1 (de) Rezeptor des ob-proteins und verwandte zusammensetzungen und verfahren
ATE93863T1 (de) Enzym-hemmende aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung.
ATE70067T1 (de) Peptidaminoalkoholderivate, welche ein tetrasubstituiertes kohlenstoffatom besitzen, hemmungsstoffe von renin und proteasesaeuren, verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE59409456D1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
PH21409A (en) Synthetic polypeptides and pharmaceutical composition containing the same
DK0552765T3 (da) benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
DE69935785D1 (de) Substitutierte aminosaeuren als erythropoietin-mimetica
DE69006888D1 (de) Verfahren zur Synthese von Acylamino-Organosilicon-Verbindungen.
WO1991015582A3 (en) Purified rap gaps, rap gap sequences, and uses thereof
FI921356A0 (fi) Somatostatinreceptor.
DK0635491T3 (da) (Thia)cycloalkylab indoler, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse forbindelser.
DE69006412T2 (de) Verfahren zur reinigung von streptokinasen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition